Table 1 Participant Demographic and Clinical Characteristics
Characteristic | Crohn’s disease n (%) | Chronic Kidney Disease n (%) |
|---|---|---|
Total | 37 (100) | 26 (100) |
Child’s age | ||
8–12 y | 6 (16) | 4 (15) |
13–17 y | 31 (84) | 22 (85) |
Female | 17 (46) | 11 (42) |
Race | ||
White | 36 (97) | 19 (73) |
Black | 0 (0) | 5 (19) |
Asian or Pacific Islander | 1 (3) | 1 (4) |
Other | 0 (0) | 1 (4) |
Hispanic ethnicity | 0 (0) | 1 (4) |
Medications used in past 12 months | ||
Oral corticosteroids | 6 (16) | n/a |
Methotrexate | 13 (35) | |
Thiopurines | 3 (8) | |
Anti-Tumor Necrosis Factor Inhibitor | 28 (76) | |
Crohn’s disease surgery past 12 months | 3 (8) | n/a |
Crohn’s disease related hospitalization past 12 months | 5 (14) | n/a |
Most Severe Physician Global Assessment of Crohn’s Disease Activity in past 12 months | ||
Inactive | 28 (76) | n/a |
Mild | 8 (21) | |
Moderate/Severe | 1 (3) | |
Glomerular kidney disease, n (%) | n/a | 5 (19) |
eGFR, n (%) | ||
15–30 mL/min/1.73 m2 | n/a | 3 (12) |
31–59 mL/min/1.73 m2 | 13 (50) | |
60+ mL/min/1.73 m2 | 10 (38) | |
Last urine protein was negative, n (%) | n/a | 11 (42) |